Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4639222
Max Phase: Preclinical
Molecular Formula: C19H21ClN6O2
Molecular Weight: 400.87
Molecule Type: Unknown
Associated Items:
ID: ALA4639222
Max Phase: Preclinical
Molecular Formula: C19H21ClN6O2
Molecular Weight: 400.87
Molecule Type: Unknown
Associated Items:
Canonical SMILES: COc1cc(N2CC(NC(=O)c3ccc4nn(C)c(C)c4c3N)C2)c(Cl)cn1
Standard InChI: InChI=1S/C19H21ClN6O2/c1-10-17-14(24-25(10)2)5-4-12(18(17)21)19(27)23-11-8-26(9-11)15-6-16(28-3)22-7-13(15)20/h4-7,11H,8-9,21H2,1-3H3,(H,23,27)
Standard InChI Key: OIQKUMPIYFHKIE-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 400.87 | Molecular Weight (Monoisotopic): 400.1415 | AlogP: 2.14 | #Rotatable Bonds: 4 |
Polar Surface Area: 98.30 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 4.75 | CX LogP: 2.49 | CX LogD: 2.49 |
Aromatic Rings: 3 | Heavy Atoms: 28 | QED Weighted: 0.65 | Np Likeness Score: -1.45 |
1. Temple KJ, Long MF, Engers JL, Watson KJ, Chang S, Luscombe VB, Rodriguez AL, Niswender CM, Bridges TM, Conn PJ, Engers DW, Lindsley CW.. (2020) Discovery of structurally distinct tricyclic M4 positive allosteric modulator (PAM) chemotypes., 30 (4): [PMID:31787491] [10.1016/j.bmcl.2019.126811] |
Source(1):